PointState Capital’s Aclaris Therapeutics ACRS Stock Holding History

PointState Capital’s Portfolio ACRS Stock Details ACRS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell
2017 Q3	$17.7M	Sell
2017 Q2	$22.7M	Sell
2017 Q1	$29M	Buy
2016 Q4	$19.5M	Buy